SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-07-22 10:17
Tx date 2019-07-17 		$NEPT
Neptune Wellness Solutions Inc. (formerly Neptune Technologies & Bioressources Inc.) 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares
16 - Acquisition or disposition under a prospectus exemption 		$880,000
+200,000 vol
$4.40 each 		600,000
Filed 2018-10-09
Tx date 2018-10-04 		$ACST
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Phase Five Partners (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$200,000
+200,000 vol
$1.00 each 		200,000
Filed 2018-10-09
Tx date 2018-10-04 		$ACST
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$341,954
+337,900 vol
$1.01 each 		387,900
Filed 2018-10-09
Tx date 2018-10-04 		$ACST
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-64,569.60
-45,600 vol
$1.42 each 		342,300
Filed 2018-10-09
Tx date 2018-10-05 		$ACST
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$9,323
+7,301 vol
$1.28 each 		349,601
Filed 2018-10-09
Tx date 2018-10-05 		$ACST
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-5,709.74
-4,261 vol
$1.34 each 		345,340
Filed 2018-10-09
Tx date 2016-07-12 		$ACST
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Phase Five Partners (Indirect Ownership)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-24
Tx date 2018-09-20 		$NEPT
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,355,431.44
-291,115 vol
$4.66 each
Filed 2018-09-24
Tx date 2018-09-20 		$NEPT
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,104,007.44
-237,115 vol
$4.66 each 		400,000
Filed 2018-09-23
Tx date 2018-09-20 		$NEPT
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-1,355,431.44
-291,115 vol
$4.66 each 		346,000
Filed 2018-03-20
Tx date 2018-03-17 		$ACST
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Options
52 - Expiration of options
-50,000 vol 		0
Filed 2018-01-11
Tx date 2018-01-05 		$NEPT
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-340,122.505
-112,885 vol
$3.01 each 		637,115
Filed 2018-01-05
Tx date 2018-01-02 		$NEPT
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-175,108.198
-71,854 vol
$2.44 each 		948,146
Filed 2018-01-05
Tx date 2018-01-05 		$NEPT
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares
11 - Acquisition or disposition carried out privately 		$-475,550.40
-198,146 vol
$2.40 each 		750,000
Filed 2017-09-05
Tx date 2016-07-12 		$ACST
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2017-09-05
Tx date 2017-08-31 		$ACST
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$80,000
+50,000 vol
$1.60 each 		50,000
Filed 2017-08-22
Tx date 2017-08-21 		$NEPT
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Interactive Brokerage (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$23,468
+26,778 vol
$0.88 each 		180,454
Filed 2017-08-22
Tx date 2017-08-18 		$NEPT
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Interactive Brokerage (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$19,587
+22,276 vol
$0.88 each 		153,676
Filed 2016-09-16
Tx date 2016-09-14 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-246,645.176
-101,680 vol
$2.43 each 		50,000
Filed 2016-08-04
Tx date 2016-08-03 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-157.00
-100 vol
$1.57 each 		151,680
Filed 2016-08-03
Tx date 2016-08-02 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-3,206.95
-2,069 vol
$1.55 each 		151,780
Filed 2016-08-01
Tx date 2016-07-28 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-310.00
-200 vol
$1.55 each 		153,849
Filed 2016-07-26
Tx date 2016-07-25 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-477.00
-300 vol
$1.59 each 		154,049
Filed 2016-07-22
Tx date 2016-07-20 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-150.00
-100 vol
$1.50 each 		154,349
Filed 2016-07-19
Tx date 2016-07-12 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-19
Tx date 2016-07-14 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-36,617.895
-23,550 vol
$1.55 each
Filed 2016-07-19
Tx date 2016-07-14 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-36,617.895
-23,550 vol
$1.55 each 		154,450
Filed 2016-07-19
Tx date 2016-07-15 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-1.60
-1 vol
$1.60 each
Filed 2016-07-19
Tx date 2016-07-15 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
10 - Acquisition or disposition in the public market 		$-1.60
-1 vol
$1.60 each 		154,449
Filed 2016-07-19
Tx date 2016-07-12 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
6 - Director or Senior Officer of 10% Security Holder
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report 		178,000
Filed 2016-07-18
Tx date 2016-07-12 		$NTB
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		1,020,000
Filed 2016-07-18
Tx date 2016-07-12 		$NTB
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-18
Tx date 2016-07-14 		$NTB
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$93,000
+75,000 vol
$1.24 each 		75,000
Filed 2016-07-18
Tx date 2016-07-12 		$NTB
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Interactive Brokerage (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		131,400
Filed 2016-07-18
Tx date 2016-07-12 		$NTB
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Schottenfeld Associates LP (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,757,086
Filed 2016-07-18
Tx date 2016-07-12 		$NTB
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-18
Tx date 2016-07-12 		$NTB
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-07-13
Tx date 2016-07-12 		$APO
Acasti Pharma Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Holder: Koyote Capital Group LLC (Indirect Ownership)
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report 		235,906
Filed 2016-07-13
Tx date 2016-07-12 		$NTB
Neptune Technologies & Bioressources Inc. 		Schottenfeld, Richard Paul
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		4,159,896